2:51
The Role Of Inflammation And Advances In ALL Treatment – Dr. Mark R. Litzow
MD Newsline
5:03
Artificial Intelligence And Clinical Trial Insights In Leukemia – Dr. Mark R. Litzow
4:19
Unanswered Questions In ALL Immunotherapy And MRD Testing – Dr. Mark R. Litzow
2:45
Personalized Leukemia Treatment For Older Adults With ALL – Dr. Mark R. Litzow
4:46
Blinatumomab FDA Approval And Chemotherapy Reduction In ALL – Dr. Mark R. Litzow
2:58
ECOG-ACRIN E1910 Study On Blinatumomab In ALL Treatment – Dr. Mark R. Litzow
3:46
How Genomic Risk And Immunotherapy Shape ALL Treatment – Dr. Mark R. Litzow
3:11
Clinical Trials vs Real World Practice in Leukemia Treatment – Dr. Mark R. Litzow
3:20
Real World Evidence In Acute Promyelocytic Leukemia And MRD Testing In ALL – Dr. Mark R. Litzow
